Many drugs fail at late stages of development due to efficacy or toxicity issues. Our services enable early identification of such issues, increasing the speed of pre-clinical development and success-rate of other candidates.
Reperia is derived from the Latin word ‘reperio’ used by the ancient roman scientists to describe their work on identifying new ways of treating diseases. Our vision is to assist today’s scientists to do this, faster, cheaper, and more effectively than ever before.
BioReperia is dedicated to providing accurate, biomedically relevant and customized services based on the needs of our customers. Within toxicology and oncology we are unique in offering bespoke, world-leading zebrafish tumor models.
Zebrafish tumor xenograft models allow identification of effective new anti-cancer agents, or existing drugs for personalized treatment on human cancer in vivo in only a few days, requiring much less drug and tumor material than any other systems.Read more
Complete toxicological analysis including LD50, MTD, NOAED and pharmacodynamics in vivo are established in only a few days, using much less drug than in other animal systems and for much lower cost. Both general and tissue-specific toxicological analyses are offered.Read more